408 related articles for article (PubMed ID: 8759757)
21. Coupling of the C5a receptor to Gi in U-937 cells and in cells transfected with C5a receptor cDNA.
Vanek M; Hawkins LD; Gusovsky F
Mol Pharmacol; 1994 Nov; 46(5):832-9. PubMed ID: 7969069
[TBL] [Abstract][Full Text] [Related]
22. G alpha-16 complements the signal transduction cascade of chemotactic receptors for complement factor C5a (C5a-R) and N-formylated peptides (fMLF-R) in Xenopus laevis oocytes: G alpha-16 couples to chemotactic receptors in Xenopus oocytes.
Burg M; Raffetseder U; Grove M; Klos A; Köhl J; Bautsch W
FEBS Lett; 1995 Dec; 377(3):426-8. PubMed ID: 8549769
[TBL] [Abstract][Full Text] [Related]
23. Differential regulation of the C3a and C5a receptors (CD88) by IFN-gamma and PMA in U937 cells and related myeloblastic cell lines.
Burg M; Martin U; Bock D; Rheinheimer C; Köhl J; Bautsch W; Klos A
J Immunol; 1996 Dec; 157(12):5574-81. PubMed ID: 8955209
[TBL] [Abstract][Full Text] [Related]
24. Stimulation of type II adenylyl cyclase by chemoattractant formyl peptide and C5a receptors.
Tsu RC; Allen RA; Wong YH
Mol Pharmacol; 1995 Apr; 47(4):835-41. PubMed ID: 7723745
[TBL] [Abstract][Full Text] [Related]
25. Chemokine production by G protein-coupled receptor activation in a human mast cell line: roles of extracellular signal-regulated kinase and NFAT.
Ali H; Ahamed J; Hernandez-Munain C; Baron JL; Krangel MS; Patel DD
J Immunol; 2000 Dec; 165(12):7215-23. PubMed ID: 11120854
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the plasma membrane bound GTPase from rabbit neutrophils. I. Evidence for an Ni-like protein coupled to the formyl peptide, C5a, and leukotriene B4 chemotaxis receptors.
Feltner DE; Smith RH; Marasco WA
J Immunol; 1986 Sep; 137(6):1961-70. PubMed ID: 3018082
[TBL] [Abstract][Full Text] [Related]
27. [Activation of astrocytes of by anaphylatoxins of the complement system].
Gamaleĭ IA; Kirpichnikova KM; Ishchenko AM; Zhakhov AV; Kliubin IV
Tsitologiia; 1998; 40(8-9):768-72. PubMed ID: 9821247
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of C5a and C3a complement fragment-induced [Ca2+]i signaling in mouse microglia.
Möller T; Nolte C; Burger R; Verkhratsky A; Kettenmann H
J Neurosci; 1997 Jan; 17(2):615-24. PubMed ID: 8987784
[TBL] [Abstract][Full Text] [Related]
29. The human chemoattractant complement C5a receptor inhibits cyclic AMP accumulation through Gi and Gz proteins.
Shum JK; Allen RA; Wong YH
Biochem Biophys Res Commun; 1995 Mar; 208(1):223-9. PubMed ID: 7887933
[TBL] [Abstract][Full Text] [Related]
30. Distinct regulation of C3a-induced MCP-1/CCL2 and RANTES/CCL5 production in human mast cells by extracellular signal regulated kinase and PI3 kinase.
Venkatesha RT; Berla Thangam E; Zaidi AK; Ali H
Mol Immunol; 2005 Mar; 42(5):581-7. PubMed ID: 15607817
[TBL] [Abstract][Full Text] [Related]
31. Complement c3a and c5a induce different signal transduction cascades in endothelial cells.
Schraufstatter IU; Trieu K; Sikora L; Sriramarao P; DiScipio R
J Immunol; 2002 Aug; 169(4):2102-10. PubMed ID: 12165538
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-33 Amplifies Human Mast Cell Activities Induced by Complement Anaphylatoxins.
West PW; Bahri R; Garcia-Rodriguez KM; Sweetland G; Wileman G; Shah R; Montero A; Rapley L; Bulfone-Paus S
Front Immunol; 2020; 11():615236. PubMed ID: 33597949
[TBL] [Abstract][Full Text] [Related]
33. C5a, but not C3a, increases VEGF secretion in ARPE-19 human retinal pigment epithelial cells.
Cortright DN; Meade R; Waters SM; Chenard BL; Krause JE
Curr Eye Res; 2009 Jan; 34(1):57-61. PubMed ID: 19172471
[TBL] [Abstract][Full Text] [Related]
34. Contrasting responses to multiple chemotactic stimuli in transendothelial migration: heterologous desensitization in neutrophils and augmentation of migration in eosinophils.
Kitayama J; Carr MW; Roth SJ; Buccola J; Springer TA
J Immunol; 1997 Mar; 158(5):2340-9. PubMed ID: 9036983
[TBL] [Abstract][Full Text] [Related]
35. C5a as a model for chemotactic factor-stimulated tyrosine phosphorylation in the human neutrophil.
Richard S; Farrell CA; Shaw AS; Showell HJ; Connelly PA
J Immunol; 1994 Mar; 152(5):2479-87. PubMed ID: 8133059
[TBL] [Abstract][Full Text] [Related]
36. C3a activates the respiratory burst in human polymorphonuclear neutrophilic leukocytes via pertussis toxin-sensitive G-proteins.
Elsner J; Oppermann M; Czech W; Kapp A
Blood; 1994 Jun; 83(11):3324-31. PubMed ID: 8193368
[TBL] [Abstract][Full Text] [Related]
37. Mast cells are not required for anaphylatoxin-induced ileal smooth muscle contraction.
Stimler-Gerard NP; Galli SJ
J Immunol; 1987 Mar; 138(6):1908-13. PubMed ID: 2434565
[TBL] [Abstract][Full Text] [Related]
38. Evidence that a receptor-operated event on the neutrophil mediates neutrophil accumulation in vivo. Pretreatment of 111In-neutrophils with pertussis toxin in vitro inhibits their accumulation in vivo.
Nourshargh S; Williams TJ
J Immunol; 1990 Oct; 145(8):2633-8. PubMed ID: 1976700
[TBL] [Abstract][Full Text] [Related]
39. The chemotactic receptor for human C5a anaphylatoxin.
Gerard NP; Gerard C
Nature; 1991 Feb; 349(6310):614-7. PubMed ID: 1847994
[TBL] [Abstract][Full Text] [Related]
40. Human plasmacytoid dendritic cells express receptors for anaphylatoxins C3a and C5a and are chemoattracted to C3a and C5a.
Gutzmer R; Köther B; Zwirner J; Dijkstra D; Purwar R; Wittmann M; Werfel T
J Invest Dermatol; 2006 Nov; 126(11):2422-9. PubMed ID: 16778800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
